A Phase 3 Double-Blind, Placebo Controlled Study to Evaluate The Safety and Efficacy OF AMG0001 In Subjects With Critical Limb Ischemia

Protocol number: AG-CLI-0206

Projected enrollment dates: November 2014 to December 2016

Official study title: A Phase 3 Double-Blind, Placebo Controlled Study to Evaluate The Safety and Efficacy OF AMG0001 In Subjects With Critical Limb Ischemia

ClinicalTrials.gov page:
http://www.clinicaltrials.gov/show/n/a

You are here

A Phase 3 Double-Blind, Placebo Controlled Study to Evaluate The Safety and Efficacy OF AMG0001 In Subjects With Critical Limb Ischemia